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VZV gK, an essential glycoprotein that is conserved among the alphaherpesviruses, is believed to participate in membrane fusion and
cytoplasmic virion morphogenesis based on analogy to its HSV-1 homolog. However, the production of VZV gK-specific antibodies has proven
difficult presumably due to its highly hydrophobic nature and, therefore, VZV gK has received limited study. To overcome this obstacle, we
inserted a FLAG epitope into gK near its amino terminus and produced VZV recombinants expressing epitope-tagged gK (VZV gK-F). These
recombinants grew indistinguishably from native VZV, and FLAG-tagged gK could be readily detected in VZV gK-F-infected cells. FACS
analysis established that gK is transported to the plasma membrane of infected cells, while indirect immunofluorescence demonstrated that gK
accumulates predominately in the Golgi. Using VZV gK-F-infected cells we demonstrated that VZV gK, like several other herpesvirus
glycoproteins, is efficiently endocytosed from the plasma membrane. However, pulse-labeling experiments revealed that the half-life of gK is
considerably shorter than that of other VZV glycoproteins including gB, gE and gH. This finding suggests that gK may be required in lower
abundance than other viral glycoproteins during virion morphogenesis or viral entry.
© 2006 Elsevier Inc. All rights reserved.Keywords: Varicella-zoster virus; Glycoprotein K; Endocytosis; Herpesvirus glycoproteinsIntroduction
Varicella-zoster (VZV) is an alphaherpesvirus that is closely
related to herpes simplex virus (HSV). Primary VZV infection
causes chickenpox, and its reactivation from latency results in
herpes zoster (shingles). VZV encodes eight membrane
glycoproteins, gB, gC, gE, gH, gI, gK, gL and gM (Davison
and Scott, 1986; Davison et al., 1986). Some of these
glycoproteins are conserved among all herpesviruses, and
others, including gK, are conserved only within the alphaher-
pesvirus subfamily. In other herpesviruses, specific combina-
tions of several of these glycoproteins promote cell-to-cell
fusion (Turner et al., 1998; Pertel, 2002; McShane and
Longnecker, 2004; Kinzler and Compton, 2005). In VZV, no
unique combination of membrane proteins has been defined as a
minimum fusion unit. Instead, several VZV proteins, individu-
ally and in various combinations, have been observed to induce⁎ Corresponding author. 3635 Vista Avenue, FDT-8N, St. Louis, MO 63110-
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doi:10.1016/j.virol.2006.08.021cellular fusion (Duus and Grose, 1996; Maresova et al., 2001;
Cole and Grose, 2003).
In contrast to HSV, infection with wild-type VZV induces
extensive syncytium formation in cultured cells. Also, cultured
cells infected with HSV produce high titers of infectious cell-
free virus whereas VZV is highly cell-associated—essentially
no infectious VZV particles are released from infected cultured
cells (Grose et al., 1979; Roizman, 1990). These differences in
the growth properties of VZV and HSV suggest that
fundamental differences may exist in the mechanisms by
which HSV and VZV spread between cells.
While syncytium formation is not normally observed as a
consequence of wild-type HSV infection, several mutations in
HSV gK have been demonstrated to confer a highly syncytial
phenotype indicating that HSV gK may function as an inhibitor
of cell-to-cell fusion (Hutchinson et al., 1993; Avitabile et al.,
2003, 2004). Furthermore, HSV gK requires the viral protein
encoded by open reading frame (ORF) UL20 to support its
function. The precise nature of the interaction between HSV gK
and UL20 protein has not been defined; however, it has been
shown that UL20 protein facilitates the intracellular transport of
Fig. 1. Structure and in vitro expression of epitope-tagged gK. (A) VZV gK
consists of 340 aa and contains four hydrophobic domains (hd1–4). It has two
consensus N-linked glycosylation sites (N55 and N65) and one YXXϕ motif
that is predicted to be cytoplasmic (YTKL). The FLAG epitope was inserted
between aa 31 and 32 to yield gK-F. (B) Untransfected cells or cells transfected
with plasmids expressing with VZV gK-F, VZV gK-F N65A, VZV gK-F N55A
or VZV gK-F N65/55A were metabolically labeled, immunoprecipitated with
anti-FLAG MAbs, and then resolved by 10% SDS-PAGE. Molecular mass in
kDa is shown.
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infected cells (Foster et al., 2003; Avitabile et al., 2004). Data
from HSV and pseudorabies virus (PRV) indicate that both gK
and UL20 protein are essential for cytoplasmic virion
morphogenesis, since capsids of mutant viruses lacking either
gK or UL20 protein accumulate within the cytoplasm and are
unable to acquire envelopes by budding into Golgi-derived
membranes (Baines et al., 1991; Foster and Kousoulas, 1999;
Foster et al., 2004a,b; Fuchs et al., 1997; Hutchinson and
Johnson, 1995; Jayachandra et al., 1997; Melancon et al., 2004).
VZV gK has received considerably less study than its HSV-1
homolog. It is predicted to be very similar in size to its HSV-1
homolog (340 amino acids (aa) [VZV] versus 338 aa [HSV]),
and like HSV-1 gK, VZV gK is predicted to possess four
membrane-spanning domains (Mo et al., 1999). Also like its
homologs in HSV and PRV, VZV gK is essential for normal
viral growth. However, the primary aa sequence of VZV gK is
only 28% identical to that of HSV-1 gK, and VZV gK cannot be
functionally complemented by its HSV-1 homolog (Mo et al.,
1999).
In this study, we use a VZV mutant expressing an epitope-
tagged form of gK to define its intracellular distribution and
demonstrate that it is internalized from the plasma membrane of
infected cells. Furthermore, we show that the half-life of gK in
infected cells is considerably less than that of other VZV
envelope glycoproteins. The implications of these findings for
the virion life cycle are discussed.
Results
Construction and characterization of epitope-tagged VZV gK
Attempts to generate VZV gK-specific monoclonal and
polyclonal antibodies using various methodologies met with
limited success (unpublished data), perhaps due in part to the
highly hydrophobic nature of gK. Moreover, the previously
reported anti-VZV gK rabbit polyclonal antibodies (generously
provided by Ann Arvin) proved insufficiently specific in our
laboratory to perform detailed analyses of gK localization and
trafficking. Therefore, in order to facilitate the detection of gK
using specific antibodies, we inserted a FLAG epitope near the
amino terminus of gK to yield gK-F (Fig. 1A). The FLAG
epitope was inserted between aa 31 and 32 of gK rather than at
the amino terminus so that it would not be removed by cleavage
of the predicted 24 aa signal sequence. To determine whether
the inserted epitope allowed detection of gK, gK-F was
transiently expressed in cultured cells, radiolabeled and
immunoprecipitated with anti-FLAGMAbs. gK-F was detected
as a 40 kDa species (Fig. 1B). While this size agrees well with
the predicted molecular mass of gK-F based on its primary aa
sequence (39 kDa when adjusted for addition of the epitope tag
and loss of its signal sequence), it is somewhat smaller than
would be predicted if the two N-linked glycosylation sites
present within its ectodomain (at aa N55 and N65) are utilized.
Therefore, in order to determine if these sites are glycosylated,
gK-F containing single amino acid mutations eliminating each
of these sites (N55A and N65A, respectively) was expressed incultured cells, radiolabeled and immunoprecipitated with anti-
FLAG MAbs. Removal of either N-linked glycosylation site
resulted in an approximately 2 kDa reduction in the molecular
mass of gK, indicating that both sites are glycosylated (Fig. 1B).
However, gK-F containing both mutations (N55A and N65A)
was not detected by immunoprecipitation suggesting that at
least one N-linked oligosaccharide must be present for gK to
maintain its native conformation.
Construction and characterization of recombinant VZV
expressing epitope-tagged gK
Infectious recombinant VZV can be generated by cotrans-
fecting large, overlapping VZV DNA fragments, cloned in
cosmid vectors that span the entire VZV genome. To generate
VZV recombinants expressing gK-F, native ORF5, which
encodes gK, was replaced by the coding sequences for gK-F
within VZV cosmid pVFsp4 to yield pVFsp4/ORF5-FLAG
(Fig. 2). pVFsp4/ORF5-FLAG was then transfected with the
other three overlapping cosmids, pVSpe5, pVPme19 and
pVSpe21, into MeWo cells. Ten days following transfection,
plaques were observed indicating the presence of infectious
virus. Two independently derived recombinants were isolated
and named VZV gK-F I and VZV gK-F II. The presence of the
FLAG coding sequences at the intended location within ORF5
in both recombinants was confirmed by sequence analysis.
Fig. 2. Construction of VZV gK-F. (A) The prototype VZV genome contains 124,884 bp (top line), and ORF5, encoding gK, is located near the left-hand end of the
VZV genome (shaded box). The VZV genome has been cloned as 4 overlapping cosmids (second and third lines; genome coordinates are shown). ORF5 is located in
cosmid pVFsp4 and spans base pairs 4355–5274 (fourth row). It is transcribed in reverse orientation (arrow) relative to the standard VZV genomic orientation. The
FLAG coding sequence (white box) was inserted in frame near the 5′-end of ORF5 (between gK codons 32 and 33).
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nant viruses, cells were infected with gK-F, radiolabeled and
immunoprecipitated using anti-FLAG MAbs. A prominent 40
kDa species was detected, indicating that gK-F is expressed by
the epitope-tagged recombinant viruses (Fig. 3).
Growth properties of recombinant VZV expressing
epitope-tagged gK
To determine whether expression of the FLAG epitope by
gK affects the ability of VZV to replicate, the growth of VZV
gK-F I and gK-F II was compared to that of native VZV during
a 6-day growth analysis. MeWo cells were inoculated with
virus-infected cells, and on days 1, 2, 3, 4 and 6 post-inoculation
the infected monolayers were harvested and the virus titers
determined. The epitope-tagged recombinant viruses grew at
rates similar to that of native VZV (Fig. 4A). In addition to the
growth rate, plaque morphologies of the epitope-tagged virusesFig. 3. Expression of VZV gK-F. Cells infected with native VZVor VZV gK-F
were metabolically labeled, immunoprecipitated using anti-FLAG antibodies
and resolved by 10% SDS-PAGE. gK-F is denoted by the arrow. Molecular mass
in kDa is shown.were compared to that of native VZV. Cells infected
simultaneously with similar titers of native VZV, VZV gK-F I
or VZV gK-F II were examined by light microscopy 4 days after
infection. The plaque sizes and morphologies of the epitope-
tagged recombinant viruses were indistinguishable from those
of native VZV (Fig. 4B). Therefore, insertion of the epitope tagsFig. 4. Growth of VZV gK-F. (A) The rates of replication of native VZVand two
independently derived VZV gK-F isolates (gK-FLAG I and gK-FLAG II) were
compared. Cells were inoculated with virus at day 0, and the log10 number of
plaques was plotted at days 1, 2, 3, 4, and 6 after infection. The log10 number of
plaques at day 0 represents the initial inoculum. (B) Cultured cells were infected
with either native VZV or VZV gK-F. Four days after inoculation the plaques
were magnified 40× by light microscopy and photographed.
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to spread between cells.
Cellular localization of VZV gK
To assess the intracellular localization of gK during
infection, MeWo cells infected with VZV gK-F were fixed
and permeabilized with paraformaldehyde containing Triton X-
100 and subjected to indirect immunofluorescence. Anti-FLAG
MAbs were used to detect gK-F, and anti-giantin antibodies
were used as a marker for the Golgi. In infected cells, the
majority of gK colocalized with giantin (Fig. 5A) indicating that
gK accumulates predominately within the Golgi during VZV
infection. In addition, lesser concentrations of gK were present
elsewhere in the cytoplasm and in the plasma membranes of
infected cells.
To confirm that VZV gK is present in the plasma membrane
of infected cells, cells infected with VZV gK-F were fixed, but
not permeabilized, and subjected to FACS analysis (Fig. 5B).
VZV gK was detected using anti-FLAG MAbs, and as a
positive control VZV gB was detected using anti-gB MAbs (gB
is abundantly expressed on the surface of VZV-infected cells
(Roizman, 1990). Uninfected cells were processed identically
and incubated with anti-FLAG MAbs, and based on this
negative control a region was defined that contains virtually no
FLAG-positive cells. However, 4.45% of cells from a VZV gK-
F-infected sample were detected within this region by anti-
FLAG MAbs, and 12.3% of cells were detected by anti-gB
MAbs. These data confirm that VZV gK is present in the plasma
membrane of infected cells. Moreover, they demonstrate that
the N-terminus of gK-F, which contains the FLAG epitope, is
exposed on the extracytoplasmic face of the plasma membrane.Fig. 5. Cellular localization of gK. (A) To assess the intracellular distribution of gK
indirect immunofluorescence using anti-FLAG (α-FLAG) and anti-giantin (α-giant
individual and merged images are shown. (B) To assess the surface expression gK,
subjected to FACS analysis using either anti-FLAG (α-FLAG) or anti-VZV gB (α-gB
cells in the negative control was defined (blue line). The percentage of gB or gK poInternalization of VZV gK
Several herpesvirus glycoproteins are internalized from the
plasma membranes of infected cells by means of specific signal
sequences, such as YXXϕmotifs, in their cytoplasmic domains.
VZV gK contains two YXXϕ motifs, one of which, YTKL (aa
177–180), is predicted to be cytoplasmic based on the
hydrophobicity profile of VZV gK and analogy to HSV-1 gK
(Fig. 1A) (Foster et al., 2001, 2003). Therefore, having shown
that VZV gK is expressed on the surface of infected cells, we
sought to determine if it is internalized from the plasma
membrane. Live cells infected with VZV gK-F were incubated
with anti-FLAGMAbs at 4 °C. The cells were then incubated at
37 °C for either 0 or 60 min (60 min having previously been
shown to be sufficient time to allow the internalization of other
VZV glycoprotein–antibody complexes (Alconada et al., 1996;
Olson and Grose, 1997; Heineman and Hall, 2001; Pasieka et
al., 2003), fixed and incubated with FITC-conjugated secondary
antibodies. The localization of gK was determined by confocal
microscopy (Fig. 6). At 0 min, gK was observed only on the
plasma membrane of infected cells. After incubation at 37 °C
for 60 min, gK was seen primarily in well-defined perinuclear
structures. These data demonstrate that VZV gK is internalized
from the plasma membrane of infected cells to structures that
are consistent in appearance and location with the Golgi.
Stability of VZV gK in infected cells
Our initial analysis of gK expression in infected cells
suggested that gK had a short half-life. In order to explore this
observation further, we performed a series of pulse-labeling
experiments and compared the stability of gK in infected cells, cells infected with VZV gK-F were fixed and permeabilized and subjected to
in) MAbs. Fluorescing cells were visualized by confocal microscopy. Both the
cells infected with native VZV (negative control) or VZV gK-F were fixed and
) Mabs (the latter as a positive control). An arbitrary region containing 0.04% of
sitive cells, defined as those within this region, are shown.
Fig. 7. Stability of gK relative to other VZV glycoproteins. (A) Cells infected
with VZV gK-F were metabolically labeled for 1 h and then incubated in non-
radioactive medium for the indicated times. VZV glycoproteins, gK-F, gB, gE
and gH were immunoprecipitated using MAbs, and then resolved by 10% SDS-
PAGE. (B) The intensity of the gK-F, gB, gE and gH signals at each time
following infection was quantitated by scanning densitometry (in arbitrary units)
and plotted as the percentage of the time 0 value (defined as 100% for each
glycoprotein). Values are the averages of three independent experiments
(mean±SD); representative experiments are shown in panel A.
Fig. 6. Internalization of gK. Cells infected VZV gK-F were incubated with anti-
FLAGMAbs at 0 °C 72 h after infection. Internalization was allowed to proceed
for 0 or 60 min at 37 °C. Cells were then fixed and permeabilized, and gK was
detected using FITC-conjugated secondary antibodies and visualized by
confocal microscopy.
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gB, gE, and gH. Cells infected with VZV gK-F were pulse
labeled for 1 h, and then incubated for 0, 1, 4 and 24 h in non-
radioactive medium. At each time point, the cells were lysed
and immunoprecipitated with MAbs specific for FLAG (to
detect gK), gB, gE or gH, and the proteins of interest were
analyzed by SDS-PAGE (Fig. 7A). Scanning densitometry
was used to assess the abundance of each glycoprotein at the
various post-labeling times, and the values were plotted as the
proportion of total protein at each time point relative to the 0 h
value for that protein (Fig. 7B). (This experiment was
performed in triplicate for each glycoprotein, and the average
values are plotted.) VZV gK had a half-life of less than 4 h
and was never detected at 24 h post-labeling. In contrast, the
level of gB decreased minimally from its peak by 24 h,
whereas the levels of gE and gH diminished to about 60% and
30% of their peak levels respectively, during the same 24-h
period.
Discussion
Compared to other VZV glycoproteins, gK has received very
little study. The single most important obstacle to the study of
VZV gK is the difficulty in producing specific antibodies,
which is presumably due largely to its highly hydrophobic
nature. While specific rabbit polyclonal antibodies have been
reported (Mo et al., 1999), they proved insufficiently sensitive
to perform the experiments reported here. Additionally, VZV
gK is expressed in infected cells in relatively low abundance
further underscoring the need for highly specific antibodies (Mo
et al., 1999). Therefore, we constructed an epitope-tagged form
of gK to facilitate its detection during both transient expression
and infection.
Our in vitro studies indicated that transiently expressed gK
containing the FLAG epitope retains the predicted character-
istics of the native protein. It migrated at the expected molecular
mass (approximately 40 kDa), and both N-linked glycosylation
sites were utilized. Interestingly, elimination of both glycosyla-
tion sites rendered the protein undetectable by immunopreci-
pitation suggesting that glycosylation of at least one site is
required for the conformational integrity of gK.Recombinant VZV expressing gK-F was generated in order
to study VZV gK during infection. VZV gK is essential for
growth of VZV in cultured cells (Mo et al., 1999). Therefore, a
significant alteration in the function of gK due to the addition of
a foreign epitope would be expected to impair the growth of the
virus. We found, however, that VZVexpressing gK-F grew at a
rate comparable to that of parental virus and induced normal-
appearing cytopathic effect in cultured cells. Thus, introduction
of a FLAG epitope near the N-terminus of gK seems to have
little effect on the functions of the protein that are essential for
VZV growth in vitro.
Like its homologs in HSV-1 and PRV (Foster et al., 2001;
Klupp et al., 1998), VZV gK expressed during infection is
present in the plasmamembrane and accumulates prominently in
the Golgi. This concentration of gK in the Golgi is presumably
due largely to its internalization from the plasma membrane,
which occurs efficiently at physiologic temperatures. HSV-1 gK
is also endocytosed from the plasma membrane (Foster et al.,
2004a,b). Thus gK joins several other herpesvirus glycoproteins,
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membrane to the Golgi (Maresova et al., 2005). VZV gK
contains a consensus YXXϕ motif that is predicted to be
cytoplasmic and may, therefore, mediate its internalization;
however, this remains to be confirmed experimentally.
Considerable evidence indicates that herpesvirus virions
mature through an envelopement–deenvelopement–reenvelo-
pement pathway. In this model, capsids acquire their initial
envelope as they pass through the inner nuclear membrane into
the perinuclear space, lose it as they are released into the
cytoplasm and then acquire their final envelope by budding
into a Golgi-derived cytoplasmic compartment. All of the
herpesvirus glycoproteins known to be internalized are
ultimately incorporated into the virion envelope and most are
thought to play a role in virion entry. Therefore, internalization
of viral glycoproteins, including gK, to the Golgi may be an
essential part of a regulatory mechanism insuring that these
glycoproteins are present in adequate quantities in the virion
envelope.
We also showed that VZV gK has a markedly shorter half-
life in infected cells than several other VZV envelope
glycoproteins. The intracellular stability of gK and other
glycoproteins may constitute an additional regulatory mechan-
ism that reflects the function of these glycoproteins during
either virion assembly or entry. Internalization of envelope
glycoproteins, as occurs with gK, gB, gE and gH, is believed to
be necessary to establish a sufficient cytoplasmic reservoir of
these proteins during virion assembly via the envelopment–
deenvelopment–reenvelopment pathway (Turcotte et al., 2005),
and it follows that the most stable glycoproteins will be more
abundant at the site of envelopment. This, in turn, may translate
into relatively higher levels of these proteins within the virion
envelope where a greater abundance of certain glycoproteins
may be required for viral entry. Additionally, relatively larger
amounts of certain glycoproteins may be required within the
Golgi-derived vesicles at which final envelopment of cytoplas-
mic capsids occurs in order to meditate, directly or indirectly,
the envelopment reaction itself. gK, which seems to act as an
inhibitor of membrane fusion during virion morphogenesis
(Melancon et al., 2005), may not be needed in as great
abundance during this process.
In summary, we used a VZV recombinant that expresses an
epitope-tagged form of gK to extend our understanding of this
essential alphaherpesvirus glycoprotein. This recombinant will
facilitate future studies of gK and its functional interactions with
other VZV membrane proteins during virus assembly and
egress.
Materials and methods
Cell culture and viruses
MeWo cells, an immortalized human melanoma cell line, and
BSC-40 cells (African green monkey kidney cells) were grown
in Eagle's minimum essential medium (EMEM) containing
10% fetal bovine serum (FBS, Bio-Whittaker) and GASP
(2mM L-glutamine, chlorotetracycline, penicillin, streptomycin;Quality Biological). Recombinant vaccinia virus vTF7-3 (Fuerst
et al., 1986) was obtained from the American Type Culture
Collection. VZV was propagated in MeWo cells, and vTF7-3
viral stocks were prepared and titered in BSC-40 cells.
Antibodies and immune reagents
M2 anti-FLAG monoclonal antibodies (MAbs) were pur-
chased from Stratagene. Anti-mouse IgG antibodies conjugated
to FITC and anti-rabbit IgG antibodies conjugated to TRITC
were obtained from Sigma. Protein G–sepharose was obtained
from Pharmacia.
DNA constructs for transient expression
To construct a plasmid from which VZV gK could be
transiently expressed, VZV ORF5, which encodes gK, was
amplified by PCR (Amplitaq DNA polymerase kit [Perkin-
Elmer]) using primers (forward—5′TGGAATTGAAGCGAAT-
TCCTAGGCTGCAAAATATC, reverse—5′TATCCAAATT-
TAGGATCCTAGGAACACAACCGT) containing EcoRI and
BamHI linkers. The resulting 1250-bp fragment was digested
with BamHI and EcoRI, and then ligated into pBluescript II
KS+(Stratagene) downstream from the T7 RNA polymerase
promoter. The FLAG epitope coding sequences were intro-
duced into the resulting construct after gK codon 31 by site-
directed mutagenesis (Muta-Gene Phagemid in vitro mutagen-
esis kit [Bio-Rad]) using the mutagenic oligonucleotide 5′
ACCGCTCGTGTAGACTACAAAGACGATGACGAC-
AAGCTCGAGCATGAGTGTGTGTAT (underline denotes the
nucleotides encoding the FLAG epitope). An XhoI site (italics)
was also introduced for screening purposes 3′ to the FLAG
epitope coding sequences. The resulting construct was called
pgK-FLAG.
Expression of epitope-tagged gK
VZV gK containing the FLAG epitope (gK-F) was expressed
by in vitro transfection of pgK-FLAG using a modified version
of the method of Fuerst et al. DNA for transfection was column
purified (Qiagen). MeWo cells at 75 to 90% confluence were
infected with vTF7-3 at a multiplicity of infection of 10 and
incubated for 15 min. The cells were then transfected with 2 μg
of DNA and 10 μl Superfect (Stratagene) for each well of a
6-well dish or 1.5 μg of DNA and 7.5 μl Superfect for each well
of a 12-well dish. Following transfection, cells were incubated
at 37 °C with 5% CO2. To express VZV gK-F by infection,
cultured cells were inoculated with VZV-infected cells and
incubated at 37 °C in 5% CO2.
Production of recombinant VZV
Recombinant virus was generated using four overlapping
cosmid vectors that span the VZV genome, pvFsp4 (nucleotides
1–33211), pvSpe5 (nucleotides 21875–62008), pvPme19
(nucleotides 53877–96188) and pvSpe21 (nucleotides 94208–
124884) (Kemble et al., 2000). ORF5, which encodes gK, spans
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3919-bp fragment (nucleotides 8205–4286) that contains all of
ORF5 except 34 nucleotides at its 3′-end was excised from
pvFsp4 by HindIII restriction digestion and cloned into
pBluescript II-KS+(Stratagene). The FLAG epitope coding
sequences, as well as an XhoI site for screening purposes, were
introduced into the resulting construct after gK codon 31 by
site-directed mutagenesis as described above. ORF5 containing
the FLAG epitope coding sequences was then excised by
digestion with HindIII and reintroduced into pvFsp4 in place of
native ORF5 to yield cosmid pvFsp4/ORF5-FLAG.
To produce recombinant virus, all four cosmids were
linearized by digestion with AscI and then transfected into
MeWo cells in 60-mm dishes using the calcium phosphate
method as previously described (Cohen and Seidel, 1993;
Heineman and Cohen, 1994). Two independently derived VZV
recombinant viruses were isolated and designated VZV gK-FI
and VZV gK-FII.
Growth characteristics of recombinant VZV
VZV titers were determined by inoculating MeWo cells with
serial 10-fold dilutions of virus-infected cells. VZV growth
curves were generated by inoculating MeWo cells in 25-cm2
flasks with infected cells containing approximately 1000 PFU
of infectious virus. Individual flasks were treated with trypsin,
and the virus titer was determined onMeWo cells at days 1, 2, 3,
4 and 6 after infection (Cohen and Seidel, 1993; Heineman and
Hall, 2002).
To compare VZV-induced plaque morphologies, cultured
cells were inoculated with similar titers of cells infected with
either native VZVor VZV expressing gK-F, incubated at 37 °C
for 4 days, and then photographed with an inverted light
microscope.
Metabolic labeling and immunoprecipitation
VZV gK-F expressed in cultured cells by transfection were
metabolically labeled 16 h after transfection, and VZV gK-F-
infected cells were labeled on days 3–4 following infection. For
steady-state labeling, cells were incubated for 1 h in EMEM
lacking cysteine and methionine and then incubated in Cys- and
Met-free EMEM containing 125 μCi of Tran35S-label (ICN) per
ml for 4 h. To pulse label, cells were incubated for 1 h in Cys- and
Met-free EMEM containing 125 μCi for Tran35S-label per ml
without prior starvation. Following the 1-h labeling period, cells
were washed and incubated for 4 h in medium (EMEM
containing 10% FBS, 24 μg of cysteine per ml and 15 μg of
methionine per ml). Labeled cells were washed extensively in
phosphate-buffered saline (PBS) at 4 °C and lysed in PBS
containing 1% Triton X-100, 0.5% deoxycholate, and 0.1%
sodium dodecyl sulfate (SDS). VZV gK was immunoprecipi-
tated by incubating the cell lysates with Staphylococcus protein
G–sepharose (Pharmacia) for 1 h at 4 °C. After washing,
immunoprecipitated proteins were eluted in sampled buffer
containing 2% SDS and 40 mM dithiothreitol (DTT) and
resolved by SDS-polyacrylamide gel electrophoresis (PAGE) on10% gels. The gels were dried, and the labeled, immunopreci-
pitated proteins were visualized by autoradiography.
Quantitation of immunoprecipitated proteins
Following autoradiography of immunoprecipitated gK, the
intensities of the gK-F signals at various time points following
pulse labeling were quantitated with a Molecular Dynamics
densitometer.
Fluorescence-activated cell-sorting (FACS) analysis of gK
Surface expression of proteins in VZV-infected cells was
determined by flow cytometry using a FACSCalibur analyzer
(Becton Dickinson). Live cells infected with VZV gK-F were
incubated with FITC-conjugated anti-FLAG MAbs (1:500 in
PBS) for 1 h at 4 °C. To assess the surface expression of VZV
gB (positive control), live VZV-infected cells were incubated
with anti-VZV gB MAbs, washed and then incubated with
FITC-conjugated goat anti-mouse IgG (1:500 dilution in PBS).
After washing with PBS, cells were fixed for 24 h in 1%
formalin prior to FACS analysis.
Confocal microscopy
MeWo cells grown on glass coverslips in 12-well dishes
were inoculated with VZV-infected cells. After 48 h, the cells
were fixed with 4% paraformaldehyde, with or without 0.2%
Triton X-100, for 1 h at 4 °C. The fixed cells were blocked with
PBS containing 1% goat serum, incubated with the anti-FLAG
MAbs (1:1000 in PBS containing 1% goat serum) overnight at
4 °C. After washing with PBS, the cells were incubated with
FITC-conjugated goat anti-mouse IgG at RT for 1 h, and the
coverslips were mounted on glass slides and viewed with a Bio-
Rad MRC 1024 laser scanning confocal microscope.
Endocytosis assay
Endocytosis assays were performed as previously described
(Heineman and Hall, 2001). Briefly, MeWo cells grown on glass
coverslips in 12-well dishes were infected with VZV gK-F.
Seventy-two hours post infection, the live cells were incubated
with anti-FLAG MAbs (1:1000 in PBS) for 1 h at 4 °C. The
cells were washed with cold PBS, and then fixed immediately or
incubated with complete medium at 37 °C for 1 h prior to
fixation. Cells were fixed with 4% paraformaldehyde contain-
ing 0.2% Triton X-100. Following fixation, the cells were
incubated with FITC-conjugated goat anti-mouse IgG, washed,
and viewed by confocal microscopy.
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